Article Details
Retrieved on: 2022-12-30 03:43:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Narnatumab, a humanized monoclonal against RON entered phase I clinical trials but failed for the lack of efficacy, in part because the antibody could ...
Article found on: www.nature.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here